Thanks for your post, as a relatively new investor, it would appear that since my first small purchase we have actually cleared the air and all the elements are in place now for this little company to join the ranks of profitable enterprises. My first buy was .70 on the way down, where it had stabilized for a time, then at .50, .40, and after it bottomed, at .43, and .54 just before the last run-up. My average share value is .50 on 30K shares. No doubt I will add as I trim other holdings, but for now am content and glad to be here.
The subject of using stops (or not) has been reviewed here before, but the morning run by MM to sweep away retail shares is worth repeating. If you don't want to lose your shares to this practice, give it a lot of room, or don't use them at all. First off this morning, down hard .40 then right back up. Here's to a good December and nice finish on the year for Huzzinpuffs!
Patents were extended in October out to 2030! DUBLIN, IRELAND--(Marketwired - Oct 1, 2014) - Horizon Pharma plc (NASDAQ: HZNP) a specialty biopharmaceutical company with a portfolio of products in arthritis, inflammation and orphan diseases, announced today that POZEN Inc. (NASDAQ: POZN), has received from the United States Patent and Trademark Office a Notice of Allowance for U.S. patent application number 12/822,612, entitled "Method for Treating a Patient at Risk for Developing an NSAID-associated Ulcer" that relates to VIMOVO® (naproxen/esomeprazole magnesium) delayed release tablets in patients taking low dose aspirin.
"This Notice of Allowance significantly expands the strength of the VIMOVO patent estate and upon issuance will extend patent protection out to 2030," said Timothy P. Walbert, chairman, president and chief executive officer, Horizon Pharma plc.
This Notice of Allowance concludes the substantive examination of the patent application and will result in the issuance of a U.S. patent after administrative processes are completed. The U.S. patent scheduled to issue from this application will expire in 2030. After issuance, Horizon and POZEN plan to list the U.S. patent in the U.S. Food and Drug Administration's Approved Drug Products with Therapeutic Equivalence Evaluations, or Orange Book. This will be the tenth U.S. patent to be listed in the Orange Book for VIMOVO.
Dividing the attention of the sales force to include cardiologists doesn't seem like it fits either company's best strategy. Before when we talked about this, I hadn't considered this, but somebody counter pitched this idea on the Pozen board, and he raised my doubts about it being a good fit.
Horse, imagine for a moment you had decided to move your money over to IDRA a week ago. I still hold 5,000 shares here, but it's feeling pretty boring, maddening even, sickening? Glad to have a large position in IDRA, and yet, SGYP has a new story yet to play out in 2015 that we're waiting on. Hope it happens for us.
The website is not worthy, where can one find the webcast replay, or for that matter a link to access the call? I looked this morning and couldn't find it. Had someone not posted the phone number here this morning, I might have missed it altogether. The stock got hit pretty hard, wouldn't you say?
I was away today but when I look at the trades leading up to the close, it was trading at 1.54 to 1.55 until it closed when the MM posts the last trade of 3,300 shares at 1.58, only down a penny. I've heard this called 'painting the tape' and yet it is usually posting a lower trade in AH. This was the MM's last act today, does anyone else have an explanation? We may have someone who is willing to pay up for trades, in the last minutes of the day. This isn't the first time I've noticed it, do we have an angel looking out for us longs?
OK, so the traders who came in last week are now flushed out, plus those who may have been holding a loss and just wanted their money back? That should have flushed most of the short term thinkers, now the stock can make a steady march into profitability, and it will float up as the scripts build. I listened to the call and left the screen with all my shares, this is an investment for me. One year plus for my shares, maybe three years. I have a lot of my positions set for a harvest in 2017 when they will have matured into much higher values.
Don't be such a jerk helping with an answer, an honest question, and he was doing jury duty while you could listen. All kinds of short tempers, why on this though?
Coolmark4you, the ID says you are for others, like it! Would you volunteer to report this once a week and then at month end for the board? We can be more effective as a board if we assign tasks to contributors. No one has asked me to do this, it's an experiment in trying to make this a better board for all. Thanks!
You were short POZN above $9, also short HZNP? It would seem so. how did you like that POZN rally today of $0.89 or 11.73%? I loved it, longs will win this minor contest, come out way ahead after SNY partnership has ended. 😁